EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Trehalose-Based Phenotypic Screen Identifies Candidate Inhibitors of Mycobacterium tuberculosis Recycling Pathway

Rebecca Vande Voorde, Aaron M Maves, Dylan Nelson, Lia Danelishvili iD

Antibiotics · 31.07.2026 · 15 (8) · 743

DOI: 10.3390/antibiotics15080743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 31.07.2026. Verfasst von Rebecca Vande Voorde und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, NIH/NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Phenotypic drug tolerance, distinct from genetic resistance, allows Mycobacterium tuberculosis (Mtb) to survive prolonged antibiotic exposure and contributes to treatment failure and relapse. The trehalose recycling pathway, mediated by the LpqY-SugABC transporter, has been implicated as a metabolic “escape” mechanism that sustains Mtb viability under antibiotic and nutrient-limiting stress, making it an attractive target for adjunctive, tolerance-breaking therapeutics. Methods and Results: Here, we conducted a high-throughput phenotypic screen of 50,000 compounds from chemically diverse libraries, using a carbon source-restricted assay that forces Mtb to rely on trehalose uptake for growth, to identify small-molecule inhibitors of this pathway. This approach yielded 23 confirmed hits in Mtb, spanning several chemical scaffolds, including thioureas, propanamides, benzamides, and carboxamides. Using an isogenic set of Mtb wild-type, LpqY-SugABC transposon knockout, and complemented strains, we confirmed that the genetic loss of transporter loss reproduces accelerated killing by isoniazid, rifampicin, and bedaquiline, but not moxifloxacin, and that loss of trehalose recycling sensitizes mycobacteria to oxidative stress. Using orthogonal functional assays, fluorescent trehalose probe (FITC-tre) uptake inhibition and H2O2 hypersensitization, thiourea-containing compounds emerged as the candidates most consistent with transporter-specific activity, phenocopying the effects of genetic LpqY-SugABC loss, while biochemical assays against recombinant trehalase (Rv2402) excluded downstream enzymatic inhibition as their mechanism of action. In addition, several hits potentiated rifampicin-mediated killing of intracellular Mtb in THP-1 macrophages, in some cases reducing bacterial burden below levels achieved by monotherapy. Conclusions: These findings indicate that the trehalose recycling pathway is functionally druggable by small molecules identified through unbiased phenotypic screening and nominate thiourea- and propanamide-based scaffolds as priority candidates for further mechanistic characterization, including direct target-engagement studies, and optimization as adjunctive anti-tuberculosis agents targeting drug-tolerant Mtb populations.

Schlagwörter

Stichwörter der Autor:innen

LpqY-SugABC transporterMycobacterium tuberculosisTrehalose recycling pathwaydrug resistancenon-replicatingpersistentsmall moleculesthe high-throughput screen

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
  • Department of Microbiology, College of Science, Oregon State University, Corvallis, OR 97331, USA.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, OR 97331, USA.

ORCID-Profile: Lia Danelishvili

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • NIH/NIAID

Zitieren

APA

Vande Voorde, R., Maves, A. M., Nelson, D., & Danelishvili, L. (2026). A Trehalose-Based Phenotypic Screen Identifies Candidate Inhibitors of Mycobacterium tuberculosis Recycling Pathway. Antibiotics, 15(8), 743. https://doi.org/10.3390/antibiotics15080743

Vancouver

Vande Voorde R, Maves AM, Nelson D, Danelishvili L. A Trehalose-Based Phenotypic Screen Identifies Candidate Inhibitors of Mycobacterium tuberculosis Recycling Pathway. Antibiotics. 2026;15(8):743. doi:10.3390/antibiotics15080743

BibTeX
@article{VandeVoorde2026,
  author = {Vande Voorde, Rebecca and Maves, Aaron M and Nelson, Dylan and Danelishvili, Lia},
  title = {A Trehalose-Based Phenotypic Screen Identifies Candidate Inhibitors of Mycobacterium tuberculosis Recycling Pathway},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {743},
  doi = {10.3390/antibiotics15080743}
}
Kostenlos starten →